Sensitivity of mycobacterium leprae to telacebec

The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis. The unprecedented potency of Telacebec against M. leprae wa...

Full description

Saved in:
Bibliographic Details
Main Authors: Lahiri, Ramanuj, Adams, Linda B., Thomas, Sangeeta Susan, Pethe, Kevin
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2022
Subjects:
Online Access:https://hdl.handle.net/10356/160139
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-160139
record_format dspace
spelling sg-ntu-dr.10356-1601392023-03-05T16:52:19Z Sensitivity of mycobacterium leprae to telacebec Lahiri, Ramanuj Adams, Linda B. Thomas, Sangeeta Susan Pethe, Kevin Lee Kong Chian School of Medicine (LKCMedicine) Science::Medicine Leprosy Telacebec The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis. The unprecedented potency of Telacebec against M. leprae warrants further validation in clinical trials. Nanyang Technological University National Research Foundation (NRF) Published version This work was supported in part by the Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant (K.P.), the National Research Foundation, Singapore, under its Investigatorship Programme (grant no. NRF-NRFI06-2020-0004), and the New York Community Trust Heiser Program (grant no. P18-000248). US National Institute of Allergy and Infectious Diseases funded the provision of viable M. leprae through an interagency agreement with Health Resources and Services Administration, Healthcare Systems Bureau, National Hansen’s Disease Program (no. AAI20009-001-00000). 2022-07-13T06:41:50Z 2022-07-13T06:41:50Z 2022 Journal Article Lahiri, R., Adams, L. B., Thomas, S. S. & Pethe, K. (2022). Sensitivity of mycobacterium leprae to telacebec. Emerging Infectious Diseases, 28(3), 749-751. https://dx.doi.org/10.3201/eid2803.210394 1080-6040 https://hdl.handle.net/10356/160139 10.3201/eid2803.210394 35202539 2-s2.0-85125256543 3 28 749 751 en NRF-NRFI06-2020-0004 Emerging Infectious Diseases 2022 Public domain. Published by the Centers for Disease Control and Prevention (CDC), a U.S. Government agency. This is an open-access article distributed under the terms of the Creative Commons Attribution License. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Medicine
Leprosy
Telacebec
spellingShingle Science::Medicine
Leprosy
Telacebec
Lahiri, Ramanuj
Adams, Linda B.
Thomas, Sangeeta Susan
Pethe, Kevin
Sensitivity of mycobacterium leprae to telacebec
description The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis. The unprecedented potency of Telacebec against M. leprae warrants further validation in clinical trials.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Lahiri, Ramanuj
Adams, Linda B.
Thomas, Sangeeta Susan
Pethe, Kevin
format Article
author Lahiri, Ramanuj
Adams, Linda B.
Thomas, Sangeeta Susan
Pethe, Kevin
author_sort Lahiri, Ramanuj
title Sensitivity of mycobacterium leprae to telacebec
title_short Sensitivity of mycobacterium leprae to telacebec
title_full Sensitivity of mycobacterium leprae to telacebec
title_fullStr Sensitivity of mycobacterium leprae to telacebec
title_full_unstemmed Sensitivity of mycobacterium leprae to telacebec
title_sort sensitivity of mycobacterium leprae to telacebec
publishDate 2022
url https://hdl.handle.net/10356/160139
_version_ 1759856457516318720